A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental Pain.

Dental pain Ibuprofen acid Ibuprofen lysinate Ibuprofen lysine Pain intensity Pain relief Postoperative dental pain

Journal

Pain and therapy
ISSN: 2193-8237
Titre abrégé: Pain Ther
Pays: New Zealand
ID NLM: 101634491

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 14 10 2019
pubmed: 9 1 2020
medline: 9 1 2020
entrez: 9 1 2020
Statut: ppublish

Résumé

Ibuprofen acid is poorly soluble in the stomach, thus reaching maximum plasma levels at approximately 90 min post-dose. Ibuprofen lysinate has been developed to accelerate absorption of ibuprofen to shorten the time to analgesic efficacy. This study compared analgesic efficacy and onset of effect of a single dose of ibuprofen lysinate or ibuprofen acid in patients undergoing third molar extraction. Randomized, double-blind, placebo-controlled, multi-center, parallel-group single-dose study. Adults (18-60 years) undergoing extraction of ≥ 1 third molar were randomized 2:2:1 to ibuprofen lysinate, ibuprofen acid, or placebo postoperatively. Pain relief (PAR, 5-point scale, 0 = none to 4 = complete pain relief) and pain intensity (PI, 100 mm visual analog scale) were assessed between 15 and 360 min post-dose. The primary endpoint was the weighted sum of PAR scores at 6 h (TOTPAR). Time to onset of effect, global assessment of efficacy, and adverse events were also assessed. Overall, 351 patients received ibuprofen lysinate (N = 141), ibuprofen acid (N = 139), or placebo (N = 71). Both active treatments significantly reduced pain compared with placebo, from 15 min post-dose to 6 h (TOTPAR: ibuprofen lysinate: 19.57; ibuprofen acid: 19.96; placebo: 8.27). Ibuprofen lysinate was significantly more effective than placebo, but non-inferior to ibuprofen acid, at providing pain relief over 6 h. There was no significant difference between ibuprofen lysinate and ibuprofen acid for onset of analgesia. Both ibuprofen formulations were well tolerated; all adverse events were mild to moderate and considered unrelated to treatment. A single dose of ibuprofen lysinate is non-inferior to ibuprofen acid in terms of analgesic efficacy, onset of action, and tolerability in patients who have recently undergone dental surgery. EudraCT No. 2006-006942-33. Plain language summary available for this article.

Identifiants

pubmed: 31912434
doi: 10.1007/s40122-019-00148-1
pii: 10.1007/s40122-019-00148-1
pmc: PMC7203382
doi:

Types de publication

Journal Article

Langues

eng

Pagination

249-259

Références

Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013;87(11):766–72.
pubmed: 23939498
Duong M, Salvo F, Pariente A, Abouelfath A, Lassalle R, Droz C, et al. Usage patterns of ‘over-the-counter’ vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. Br J Clin Pharmacol. 2014;77(5):887–95.
doi: 10.1111/bcp.12239
Moore RA, Derry S, Aldington D, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults—an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;(9):CD008659. https://doi.org/10.1002/14651858.CD008659.pub3 .
Moore RA, Derry S, Straube S, Ireson-Paine J, Wiffen PJ. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014;155(1):14–21.
doi: 10.1016/j.pain.2013.08.013
Moore RA, Derry S, Straube S, Ireson-Paine J, Wiffen PJ. Validating speed of onset as a key component of good analgesic response in acute pain. Eur J Pain. 2015;19(2):187–92.
doi: 10.1002/ejp.536
Irvine J, Afrose A, Islam N. Formulation and delivery strategies of ibuprofen: challenges and opportunities. Drug Dev Ind Pharm. 2018;44(2):173–83.
doi: 10.1080/03639045.2017.1391838
Moore RA, Derry S, Wiffen PJ, Straube S. Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs—a systematic review. Br J Clin Pharmacol. 2015;80(3):381–8.
doi: 10.1111/bcp.12628
Au AH, Choi SW, Cheung CW, Leung YY. The efficacy and clinical safety of various analgesic combinations for post-operative pain after third molar surgery: a systematic review and meta-analysis. PLoS One. 2015;10(6):e0127611.
doi: 10.1371/journal.pone.0127611
Cooper SA, Desjardins PJ. The value of the dental impaction pain model in drug development. Methods Mol Biol. 2010;617:175–90.
doi: 10.1007/978-1-60327-323-7_15
Cooper SA, Desjardins PJ, Turk DC, Dworkin RH, Katz NP, Kehlet H, et al. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain. 2016;157(2):288–301.
doi: 10.1097/j.pain.0000000000000375
Black P, Max MB, Desjardins P, Norwood T, Ardia A, Pallotta T. A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain. Clin Ther. 2002;24(7):1072–89.
doi: 10.1016/S0149-2918(02)80020-0
Desjardins P, Black P, Papageorge M, Norwood T, Shen DD, Norris L, et al. Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol. 2002;58(6):387–94.
doi: 10.1007/s00228-002-0491-0
Mehlisch DR, Ardia A, Pallotta T. A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. J Clin Pharmacol. 2002;42(8):904–11.
doi: 10.1177/009127002401102821
Mehlisch DR, Jasper RD, Brown P, Korn SH, McCarroll K, Murakami AA. Comparative study of ibuprofen lysine and acetaminophen in patients with postoperative dental pain. Clin Ther. 1995;17(5):852–60.
doi: 10.1016/0149-2918(95)80063-8
Derry S, Wiffen PJ, Moore RA, Bendtsen L. Ibuprofen for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev. 2015;(7):CD011474. https://doi.org/10.1002/14651858.CD011474.pub2 .
Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;(4):CD008039. https://doi.org/10.1002/14651858.CD008039.pub3 .
Heintze K, Fuchs W. Effects of food on pharmacokinetics of immediate release oral formulations. Br J Clin Pharmacol. 2015;80(5):1239.
doi: 10.1111/bcp.12712
Klueglich M, Ring A, Scheuerer S, Trommeshauser D, Schuijt C, Liepold B, et al. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol. 2005;45(9):1055–61.
doi: 10.1177/0091270005279579
Weiser T, Schepers C, Muck T, Lange R. Pharmacokinetic properties of ibuprofen (IBU) from the fixed-dose combination IBU/caffeine (400/100 mg; FDC) in comparison with 400 mg IBU as acid or lysinate under fasted and fed conditions-data from 2 single-center, single-dose, randomized crossover studies in healthy volunteers. Clin Pharmacol Drug Dev. 2019;8(6):742–53.
pubmed: 30897305 pmcid: 6767367
Mehlisch DR, Aspley S, Daniels SE, Bandy DP. Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: a randomized, double-blind, placebo-controlled, parallel-group, single-dose, two-center, modified factorial study. Clin Ther. 2010;32(5):882–95.
doi: 10.1016/j.clinthera.2010.04.022
Mehlisch DR, Aspley S, Daniels SE, Southerden KA, Christensen KS. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study. Clin Ther. 2010;32(6):1033–49.
doi: 10.1016/j.clinthera.2010.06.002
Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281. https://doi.org/10.1002/14651858.CD009281.pub3 .
Weiser T, Richter E, Hegewisch A, Muse DD, Lange R. Efficacy and safety of a fixed-dose combination of ibuprofen and caffeine in the management of moderate to severe dental pain after third molar extraction. Eur J Pain. 2018;22(1):28–38.
doi: 10.1002/ejp.1068

Auteurs

Ján Kyselovič (J)

Clinical Research Unit, 5th Department of Internal Medicine, Medical Faculty of Comenius University, University Hospital, Bratislava, Slovak Republic.

Eva Koscova (E)

CHC Medical Affairs, Eastern Europe Zone, Sanofi-Aventis Pharma Slovakia s.r.o, Bratislava, Slovak Republic.

Anette Lampert (A)

Medical CHC, Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, Germany.

Thomas Weiser (T)

Medical CHC, Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, Frankfurt, Germany. thomas.weiser@sanofi.com.

Classifications MeSH